US Ties Health Aid to Data Sharing in 7 African Countries
US health aid to seven African countries now requires sharing of pathogen samples and surveillance data.
Why it matters: These agreements affect data privacy, sovereignty, and compliance for legal and regulatory teams managing international health programs.
- In late 2025, the US signed health aid agreements with Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, Liberia, and Uganda conditioning aid on sharing pathogen samples and disease surveillance data.
- Noncompliance risks withdrawal of all funding, after prior $800 million cutbacks in early 2025.
- Agreements were briefly posted in March 2026 to the US State Department FOIA Library, then removed following public scrutiny.
- Over 60 civil society groups objected in a December 2025 letter; Ghana and Zimbabwe formally opposed or withdrew due to privacy and sovereignty concerns.
In late 2025, the United States signed bilateral health agreements with seven African countries—Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, Liberia, and Uganda—that link critical health assistance to sharing pathogen samples and infectious disease surveillance data. These agreements require recipient nations to provide biological materials and data related to emerging diseases with epidemic or pandemic potential, raising concerns around data privacy and sovereignty.
Failure to comply with these data-sharing provisions risks the full withdrawal of health funding. This follows prior funding cuts exceeding $800 million in early 2025 that already strained public health programs. The agreements were briefly posted on March 13, 2026, to the US State Department's Freedom of Information Act (FOIA) Library, but were swiftly removed after media scrutiny Reuters.
More than 60 African civil society organizations expressed opposition in a December 2025 letter posted by the Africa Center for Strategic Studies. Ghana formally withdrew from related negotiations in April 2026, citing intrusive data demands GhanaWeb. Zimbabwe's Information Secretary Nick Mangwana told The Herald that aid "should empower nations, not serve as a vehicle for strategic extraction," emphasizing sovereignty concerns.
Legal experts highlight risks related to patient confidentiality and the absence of explicit safeguards preventing sharing of sensitive health data with US pharmaceutical companies without consent. These terms raise legal and ethical questions for privacy and compliance officers responsible for cross-border health programs. The agreements may also undermine ongoing negotiations at the World Health Organization for a global pathogen access and benefit-sharing framework aimed at equitable health outcomes.
Julia Bleckner, senior health researcher at Human Rights Watch, states, "The agreements show the US intends to condition vital health assistance on acceptance of troubling data access terms" Human Rights Watch. Zimbabwean official Nick Mangwana stressed ethical aid practices in interviews.
These developments prompt important legal discussions about international aid conditionality, individual privacy rights, and national sovereignty in global health security frameworks.
By the numbers:
- 7 African countries involved — Ethiopia, Kenya, Mozambique, Nigeria, Rwanda, Liberia, Uganda
- $800 million — prior US health aid cuts in early 2025
- 60+ civil society groups — signed letter opposing data-sharing conditions
Yes, but: While the agreements raise privacy concerns, proponents argue linking aid to data sharing improves global disease surveillance and pandemic response capacity.
What's next: Ongoing negotiations at the World Health Organization on a pathogen access and benefit-sharing treaty could be impacted by these bilateral agreements' data policies.